Category
Clinical Guidelines And Protocols
Articles in this category

7/31/2026
Warsaw’s Orthopaedic Capital of the World Charts a New Course at OrthoWorx Summit
Warsaw, Indiana is home to over 100 orthopedic companies and a workforce 272 times more specialised in orthopedics than anywhere else in the United States. Can this rural community hold its title as the Orthopaedic Capital of the World as healthcare economics and care delivery models transform?
Read Article →
7/31/2026
Future HIV Control in Africa Demands Bold Leadership
Is Africa's HIV future at a crossroads?
The Africa HIV Control Working Group's 2026 webinar spotlighted UNAIDS, UNICEF & health leaders on domestic financing, sovereignty, integrated systems & community leadership to build resilient HIV control.
Read more & join the push for bold action.
#HIVControl #AfricaHealth #BoldLeadership #UNAIDS #GlobalHealth
Read Article →
7/23/2026
CMS Digital Therapeutics Coverage Model for Chronic Care Devices
How is CMS reshaping coverage for digital therapeutics in chronic care?
The new model aims to expand access to digital therapeutics and connected devices, helping providers deliver more effective, tech-enabled support for chronic conditions.
Discover what this means for payers, innovators, and patients.
#SyenzaNews #digitalhealth #HealthcareInnovation #innovation #DigitalTransformation
Read Article →
7/15/2026
Digital Medical Device Regulations Enable Rapid Approvals
🚀 What if smarter regulations could fast-track digital medical device approvals?
Recent updates are streamlining pathways for MedTech innovators, cutting timelines while maintaining rigorous safety standards. This shift is accelerating patient access to next-generation health technologies.
Read the full analysis to see what it means for your pipeline.
#SyenzaNews #medicaldevices #regulatoryaffairs #innovation #DigitalTransformation
Read Article →
7/14/2026
PIMART South Africa HIV pharmacists Boost Treatment Access
💊 How are pharmacists expanding HIV treatment access across South Africa?
Through the PIMART initiative, trained pharmacists can now initiate antiretroviral therapy, closing critical gaps in care and reaching more patients in underserved communities.
Discover how this model is reshaping service delivery and outcomes.
#SyenzaNews #pharmaceuticals #globalhealth #MarketAccess #innovation
Read Article →
7/6/2026
Impact of Practice-Level Telehealth on Quality Outcomes in Chronic Care
Can practice-level telehealth really improve quality and outcomes for people with chronic conditions? 📲
This article distills evidence and practice examples showing how well-integrated telehealth—backed by workflow redesign, staff training, and equity-focused access—can boost continuity of care, adherence, and patient engagement while revealing common implementation pitfalls.
Read the full article for practical steps, metrics to track, and policy considerations to make telehealth work for chronic care. ✅
#SyenzaNews #digitalhealth #HealthTech #DigitalTransformation #healthcarepolicy
Read Article →
6/24/2026
Cemiplimab Cervical Cancer Access Navigating Treatment and Value
Could cemiplimab reshape cervical cancer care — and what does that mean for access and value? 🔬
This article unpacks the clinical benefits seen in recent studies, the pricing and reimbursement hurdles limiting patient access, and pragmatic value-based strategies (e.g., managed entry agreements, budget impact framing) for payers and policymakers.
Read the full analysis to learn how stakeholders can balance innovation with affordability and improve real-world access. 💡
#SyenzaNews #oncology #HealthEconomics #MarketAccess #costeffectiveness
Read Article →
6/22/2026
Lingjian Morphology Diagnostics Transforming Clinical Laboratory Practices
Could AI‑powered morphology be the next leap for clinical laboratories? 🔬
Lingjian’s morphology diagnostics platform pairs high‑resolution digital microscopy with machine learning to automate cell analysis, improve diagnostic accuracy, and speed turnaround times—while integrating with lab systems to standardize workflows and lower costs.
Read the full article to learn how labs can validate, implement, and benefit from this technology. ⚡
#SyenzaNews #MedTech #AIinHealthcare #DigitalTransformation #innovation
Read Article →
6/19/2026
LesionAttn Skin Cancer AI Enhances Fairness in Dermatological Diagnostics
Can AI make skin cancer detection fairer across skin tones? 🩺🤖
A lesion-attention AI model that focuses on the lesion area reduces diagnostic bias and improves accuracy for darker skin tones while maintaining overall performance, offering a practical step toward more equitable dermatology tools. The paper details model design, evaluation on diverse datasets, and implications for clinical deployment.
Read the full article to explore the methods, results, and what this means for clinicians, developers, and policymakers.
#SyenzaNews #medicalimaging #AIinHealthcare #ai #innovation
Read Article →
6/18/2026
Rising Trends in Early-Onset Colorectal Cancer Burden
Are rising rates of early-onset colorectal cancer a ticking public‑health time bomb? 📈🩺
New evidence shows incidence is climbing among younger adults, shifting the screening, treatment, and economic burden onto health systems and working-age populations — with urgent implications for prevention, diagnostics, and resource planning.
Read the full article to understand the trends, policy implications, and practical steps stakeholders can take.
#SyenzaNews #oncology #globalhealth #healthcarepolicy #resourceallocation
Read Article →
6/17/2026
Enhancing Health Technology Assessment Through Real-World Evidence in Portugal
Could Portugal's use of real‑world evidence transform HTA and speed patient access? 🔍🇵🇹
This article explains Portugal’s adaptive HTA pilots — how iterative decision frameworks, real‑world data and stakeholder‑aligned reimbursement models help manage uncertainty while enabling earlier access to innovative therapies. It draws out practical lessons for payers, manufacturers and policymakers aiming to modernize market access.
Read the full piece to explore the enablers, pilot insights and implications for future HTA design.
#SyenzaNews #HealthEconomics #regulatoryaffairs #MarketAccess #healthcarepolicy
Read Article →
6/16/2026
Advancing Real-World Evidence AI in Medicines Regulation
Can AI + real-world evidence transform how medicines are regulated?
Regulators are increasingly leveraging RWE and AI to speed approvals, strengthen post‑market surveillance, and enable more patient‑centered decisions — but success depends on data quality, transparent algorithms, and cross‑sector collaboration. This article outlines emerging frameworks, key risks to manage, and practical steps for regulators, industry, and tech partners.
Read the full piece to see how stakeholders can responsibly scale RWE and AI in medicines regulation. 🔍
#SyenzaNews #regulatoryaffairs #AIinHealthcare #ai #healthcarepolicy
Read Article →


